Press Releases

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company in China focusing on oncology and autoimmune diseases, won the award of "Biosimilar Initiative of the Year" (HLX01, rituximab injection) and was also shortlisted for the award of "the Company of the Year,

STOCKHOLM, Nov. 6, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from the clinical program evaluating its lead candidate melflufen in multiple myeloma and Light Chain (AL) Amyloidosis have been selected for six poster presentations to be featured at the American Society of Hematology (ASH) 2019 Annual Meeting taking place

CAMBRIDGE, Mass., Nov. 6, 2019 /PRNewswire/ -- New clinical data from Sanofi's oncology and rare blood disorders portfolios and pipelines will be featured, including four oral presentations and 18 posters, at the 61st American Society of Hematology (ASH) Annual Meeting & Exposition from December 7-10 in

BETHESDA, Md. and CINCINNATI, Nov. 6, 2019 /PRNewswire/ -- InFuse Holdings Inc. announced today a Series A investment led by BroadOak Capital Partners to build a network of high-quality, cost-effective infusion centers throughout Ohio and the Midwest.  The initial funding will be used to acquire

NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced that interim results from a Phase 1 trial studying Actimab-A in combination with CLAG-M have been accepted for presentation at the 2019 American Society of Hematology (ASH) annual meeting that is being held Dece

SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Viracta Therapeutics, Inc. (the "Company"), a precision oncology company targeting virus-associated malignancies, announced today that its lead investigator, Dr

SEATTLE, Nov. 6, 2019 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced four poster presentations and one oral presentation supporting the Company's pacritinib develo

BRIDGEWATER, N.J., Nov. 6, 2019 /PRNewswire/ -- Nestlé Health Science announced today the three winners of the tenth annual OPTIFAST® "New You" contest. The OPTIFAST® program is a medically-monitored, meal replacement weight loss program and the "New You" contest celebrates their achievements. The three winners were flown to

LEXINGTON, Mass., Nov. 6, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that abstracts for both fimepinostat and CA-4948 were accepted for presentation at the 61st Annual Meeting of the American Society of Hematology (ASH) which will be

NEW HAVEN, Conn., Nov. 6, 2019 /PRNewswire/ -- Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds designed to emulate or e